1. Home
  2. KYMR vs MEOH Comparison

KYMR vs MEOH Comparison

Compare KYMR & MEOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • MEOH
  • Stock Information
  • Founded
  • KYMR 2015
  • MEOH 1968
  • Country
  • KYMR United States
  • MEOH Canada
  • Employees
  • KYMR N/A
  • MEOH N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • MEOH Major Chemicals
  • Sector
  • KYMR Health Care
  • MEOH Industrials
  • Exchange
  • KYMR Nasdaq
  • MEOH Nasdaq
  • Market Cap
  • KYMR 3.1B
  • MEOH 2.7B
  • IPO Year
  • KYMR 2020
  • MEOH N/A
  • Fundamental
  • Price
  • KYMR $43.51
  • MEOH $38.61
  • Analyst Decision
  • KYMR Strong Buy
  • MEOH Buy
  • Analyst Count
  • KYMR 15
  • MEOH 9
  • Target Price
  • KYMR $58.53
  • MEOH $46.89
  • AVG Volume (30 Days)
  • KYMR 722.6K
  • MEOH 371.3K
  • Earning Date
  • KYMR 10-30-2025
  • MEOH 11-05-2025
  • Dividend Yield
  • KYMR N/A
  • MEOH 1.92%
  • EPS Growth
  • KYMR N/A
  • MEOH 62.76
  • EPS
  • KYMR N/A
  • MEOH 3.48
  • Revenue
  • KYMR $44,711,000.00
  • MEOH $3,576,740,000.00
  • Revenue This Year
  • KYMR $58.45
  • MEOH $6.67
  • Revenue Next Year
  • KYMR N/A
  • MEOH $10.89
  • P/E Ratio
  • KYMR N/A
  • MEOH $11.07
  • Revenue Growth
  • KYMR N/A
  • MEOH N/A
  • 52 Week Low
  • KYMR $19.45
  • MEOH $25.46
  • 52 Week High
  • KYMR $53.27
  • MEOH $54.49
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 53.28
  • MEOH 73.41
  • Support Level
  • KYMR $39.84
  • MEOH $34.70
  • Resistance Level
  • KYMR $43.43
  • MEOH $35.84
  • Average True Range (ATR)
  • KYMR 2.03
  • MEOH 0.98
  • MACD
  • KYMR 0.15
  • MEOH 0.33
  • Stochastic Oscillator
  • KYMR 78.76
  • MEOH 98.89

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About MEOH Methanex Corporation

Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through an extensive supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.

Share on Social Networks: